PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Ciclosporin - Transplant immunosuppression
PAD Profile : Ciclosporin - Transplant immunosuppression
Brand Names Include :
Neoral, Sandimmun
Traffic Light Status
Status 1 of 2.
Status :
Red
Important
Formulations :
- Capsules
- Oral solution
Important Information :
For NEW patients: RED drug for post-transplant. Funded by NHS England. GPs should not accept any new requests to prescribe post-transplant.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Blue
Important
Formulations :
- Not Specified
Important Information :
For EXISTING patients only: GPs may continue to prescribe for existing post-transplant patients only. MHS England are looking to repatriate the patients in the future. GPs must not accept requests to prescribe for new patients.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
- Dermatology indications
- Psoriatic arthritis
- Inflammatory bowel disease
- Dry eyes
- Dry eyes
- Allergic conjunctivitis
- Neurology indications
- Uveitis
- Renal indications
- Rheumatology indications
- Ocular surface disease
- Alopecia
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
01 April 2013
Not Set
FOR EXISTING PATIENTS: GPs should continue to prescribe these treatments. NHS England are looking to repatriate these patients in the future. The Medicines Management Team will be in contact with prescribers when they have more information
FOR NEW PATIENTS ONLY: The prescribing of Ciclosporin is considered a RED drug post transplant only and is now funded via NHS England for this indication.
Associated BNF Codes
08. Malignant Disease and Immunosuppression
08.02.02. Corticosteroids and other immunosuppressants